MyoKardia Inc (MYOK)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: MYOK Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-07 2020-07-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,224 -14.4%
94.22
USD 303,767 		3,224 -14.4% 94.22 USD 303,767
2020-07-07 2020-07-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,776 -7.4%
93.55
USD 166,142 		1,776 -7.4% 93.55 USD 166,142
2020-07-01 2020-06-30 S Sale

CRANSTON MARY B

Non-Executive Director
21,329 -100.0%
96.59
USD 2,060,179 		21,329 -100.0% 96.59 USD 2,060,179
2020-07-01 2020-06-30 S Sale

CRANSTON MARY B

Non-Executive Director
300 -1.4%
97.25
USD 29,176 		300 -1.4% 97.25 USD 29,176
2020-07-01 2020-06-29 S Sale

CRANSTON MARY B

Non-Executive Director
371 -100.0%
98.68
USD 36,611 		371 -100.0% 98.68 USD 36,611
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
319 -1.3%
104.64
USD 33,382 		319 -1.3% 104.64 USD 33,382
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,885 -7.2%
103.77
USD 195,609 		1,885 -7.2% 103.77 USD 195,609
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,396 -5.0%
102.78
USD 143,481 		1,396 -5.0% 102.78 USD 143,481
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
800 -2.8%
101.72
USD 81,378 		800 -2.8% 101.72 USD 81,378
2020-06-04 2020-06-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -2.1%
100.60
USD 60,357 		600 -2.1% 100.60 USD 60,357
2020-05-20 2020-05-18 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
10,000 -25.6%
125.00
USD 1,250,000 		10,000 -25.6% 125.00 USD 1,250,000
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -1.5%
103.33
USD 61,998 		600 -1.5% 103.33 USD 61,998
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,519 -8.1%
102.56
USD 360,921 		3,519 -8.1% 102.56 USD 360,921
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
18,581 -30.1%
101.90
USD 1,893,486 		18,581 -30.1% 101.90 USD 1,893,486
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,700 -2.7%
100.51
USD 170,860 		1,700 -2.7% 100.51 USD 170,860
2020-05-13 2020-05-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.9%
98.69
USD 59,213 		600 -0.9% 98.69 USD 59,213
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
305 -0.4%
60.15
USD 18,346 		305 -0.4% 60.15 USD 18,346
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,909 -3.8%
59.10
USD 171,916 		2,909 -3.8% 59.10 USD 171,916
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
400 -0.5%
58.05
USD 23,218 		400 -0.5% 58.05 USD 23,218
2020-05-06 2020-05-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,386 -1.8%
56.93
USD 78,907 		1,386 -1.8% 56.93 USD 78,907
2020-04-20 2020-04-16 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.3%
55.00
USD 55,000 		1,000 -1.3% 55.00 USD 55,000
2020-04-10 2020-04-08 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,500 -1.9%
50.00
USD 75,000 		1,500 -1.9% 50.00 USD 75,000
2020-04-07 2020-04-06 S Sale

Harris Taylor C.

Chief Financial Officer

Officer
1,305 -14.9%
46.99
USD 61,322 		1,305 -14.9% 46.99 USD 61,322
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.8%
46.23
USD 27,736 		600 -0.8% 46.23 USD 27,736
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.4%
45.35
USD 13,605 		300 -0.4% 45.35 USD 13,605
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.2%
44.47
USD 44,469 		1,000 -1.2% 44.47 USD 44,469
2020-04-06 2020-04-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.7%
43.51
USD 26,107 		600 -0.7% 43.51 USD 26,107
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
22 -0.0%
65.97
USD 1,451 		22 -0.0% 65.97 USD 1,451
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,800 -2.2%
65.19
USD 117,346 		1,800 -2.2% 65.19 USD 117,346
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,070 -2.4%
64.35
USD 133,203 		2,070 -2.4% 64.35 USD 133,203
2020-03-04 2020-03-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,108 -1.3%
63.40
USD 70,246 		1,108 -1.3% 63.40 USD 70,246
2020-02-05 2020-02-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.1%
69.74
USD 69,744 		1,000 -1.1% 69.74 USD 69,744
2020-02-05 2020-02-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,000 -4.4%
69.27
USD 277,077 		4,000 -4.4% 69.27 USD 277,077
2020-02-03 2020-02-01 S Sale

Fairey William

See Remarks
2,899 -35.7%
68.04
USD 197,248 		2,899 -35.7% 68.04 USD 197,248
2020-01-14 2020-01-14 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
75.39
USD 376,965 		5,000 -5.2% 75.39 USD 376,965
2020-01-07 2020-01-06 S Sale

Harris Taylor C.

Chief Financial Officer
1,683 -25.2%
68.45
USD 115,203 		1,683 -25.2% 68.45 USD 115,203
2020-01-07 2020-01-06 S Sale

LADD CYNTHIA J

General Counsel
1,849 -39.3%
68.45
USD 126,566 		1,849 -39.3% 68.45 USD 126,566
2020-01-07 2020-01-06 S Sale

McDowell Robert Scott

Chief Scientific Officer
2,650 -33.0%
68.45
USD 181,395 		2,650 -33.0% 68.45 USD 181,395
2020-01-07 2020-01-06 S Sale

Bauer Jake

Chief Business Officer
2,466 -4.1%
68.45
USD 168,800 		2,466 -4.1% 68.45 USD 168,800
2020-01-07 2020-01-06 S Sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
12,687 -11.6%
68.45
USD 868,439 		12,687 -11.6% 68.45 USD 868,439
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,084 -1.9%
72.27
USD 150,617 		2,084 -1.9% 72.27 USD 150,617
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,616 -2.3%
71.59
USD 187,287 		2,616 -2.3% 71.59 USD 187,287
2020-01-03 2020-01-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.3%
70.35
USD 21,105 		300 -0.3% 70.35 USD 21,105
2019-12-23 2019-12-20 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
18,916 -30.3%
70.07
USD 1,325,421 		18,916 -30.3% 70.07 USD 1,325,421
2019-12-04 2019-12-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,350 -4.8%
65.14
USD 283,342 		4,350 -4.8% 65.14 USD 283,342
2019-12-04 2019-12-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
650 -0.7%
64.24
USD 41,755 		650 -0.7% 64.24 USD 41,755
2019-12-02 2019-11-29 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
800 -1.7%
66.32
USD 53,056 		800 -1.7% 66.32 USD 53,056
2019-12-02 2019-11-29 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
7,336 -13.8%
65.52
USD 480,655 		7,336 -13.8% 65.52 USD 480,655
2019-12-02 2019-11-27 PS Planned sale

Bauer Jake

Chief Business Officer

Officer
13,096 -19.8%
65.13
USD 852,977 		13,096 -19.8% 65.13 USD 852,977
2019-11-06 2019-11-04 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
59.07
USD 295,365 		5,000 -5.2% 59.07 USD 295,365
2019-10-04 2019-10-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
USD 55,000 		1,000 -1.0% 55.00 USD 55,000
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
758 -0.8%
53.10
USD 40,248 		758 -0.8% 53.10 USD 40,248
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,542 -2.5%
52.29
USD 132,933 		2,542 -2.5% 52.29 USD 132,933
2019-10-04 2019-10-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
700 -0.7%
51.33
USD 35,930 		700 -0.7% 51.33 USD 35,930
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
4,161 -50.0%
61.09
USD 254,191 		4,161 -50.0% 61.09 USD 254,191
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
800 -8.8%
59.95
USD 47,960 		800 -8.8% 59.95 USD 47,960
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
4,161 -31.3%
58.97
USD 245,389 		4,161 -31.3% 58.97 USD 245,389
2019-09-24 2019-09-23 PS Planned sale

Lee June

EVP, Chief Development Officer
3,929 -22.8%
58.33
USD 229,184 		3,929 -22.8% 58.33 USD 229,184
2019-09-24 2019-09-20 PS Planned sale

Bauer Jake

Chief Business Officer
19,700 -23.0%
60.09
USD 1,183,777 		19,700 -23.0% 60.09 USD 1,183,777
2019-09-20 2019-09-19 PS Planned sale

Lee June

EVP, Chief Development Officer
5,435 -54.3%
57.08
USD 310,254 		5,435 -54.3% 57.08 USD 310,254
2019-09-12 2019-09-11 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
USD 55,000 		1,000 -1.0% 55.00 USD 55,000
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,100 -1.1%
54.09
USD 59,500 		1,100 -1.1% 54.09 USD 59,500
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
52.75
USD 52,750 		1,000 -1.0% 52.75 USD 52,750
2019-09-05 2019-09-03 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,900 -1.8%
50.70
USD 96,335 		1,900 -1.8% 50.70 USD 96,335
2019-08-12 2019-08-09 PS Planned sale

Lee June

EVP, Chief Development Officer

Officer
4,565 -49.9%
57.00
USD 260,219 		4,565 -49.9% 57.00 USD 260,219
2019-08-09 2019-08-08 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.09
USD 55,090 		1,000 -0.9% 55.09 USD 55,090
2019-08-05 2019-08-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
200 -0.2%
53.82
USD 10,764 		200 -0.2% 53.82 USD 10,764
2019-08-05 2019-08-02 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,800 -3.4%
53.20
USD 202,171 		3,800 -3.4% 53.20 USD 202,171
2019-07-23 2019-07-22 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.00
USD 55,000 		1,000 -0.9% 55.00 USD 55,000
2019-07-08 2019-07-05 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,450 -2.1%
50.10
USD 122,752 		2,450 -2.1% 50.10 USD 122,752
2019-07-08 2019-07-05 PS Planned sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,550 -1.3%
49.13
USD 76,151 		1,550 -1.3% 49.13 USD 76,151
2019-04-09 2019-04-05 S Sale

Harris Taylor C.

Chief Financial Officer
1,324 -35.3%
53.30
USD 70,569 		1,324 -35.3% 53.30 USD 70,569
2019-02-15 2019-02-13 S Sale

Sanofi

Large shareholder
4,168,899 -100.0%
37.66
USD 157,000,736 		4,168,899 -100.0% 37.66 USD 157,000,736
2019-01-11 2019-01-07 S Sale

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,770 -3.5%
44.11
USD 122,197 		2,770 -3.5% 44.11 USD 122,197
2019-01-08 2019-01-04 B Purchase

GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,600 +1.8%
39.87
USD 63,796 		1,600 +1.8% 39.87 USD 63,796
// ... existing code ... // ... rest of the file ...